Suzanne Runge
Family · Fort Pierce, FLNPI 1245663038
Payments from drug & device makers
Across 121 payments — averaging $20.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$376
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$277
- Pfizer$162
- Abbott$156
- Johnson & Johnson$140
- AbbVie$133
- plus $1K from 20 others
What the payments were for
- Food & beverage$2,439100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 19 | $376 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $277 |
| Pfizer | 9 | $162 |
| Abbott | 8 | $156 |
| Johnson & Johnson | 4 | $140 |
| AbbVie | 6 | $133 |
| Amgen | 7 | $132 |
| Lilly USA, LLC | 8 | $131 |
| Bayer | 6 | $125 |
| Novartis | 7 | $116 |
| GSK | 6 | $110 |
| Exact Sciences | 5 | $92 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $89 |
| Amarin Pharma, Inc. | 3 | $58 |
| Boston Scientific | 2 | $58 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $55 |
| Sanofi-aventis U.S. LLC | 3 | $49 |
| Boehringer Ingelheim | 1 | $31 |
| Almatica Pharma LLC | 1 | $25 |
| IBSA Pharma Inc. | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $19 |
| Merck | 1 | $18 |
| Sonex Health, Inc. | 1 | $17 |
| Philips North America LLC | 1 | $15 |
| Novo Nordisk | 1 | $13 |
How this compares
$2,439 in reported general payments places this provider in the 85th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 31 | $38,126 |
| EliquisApixaban | 18 | $26,414 |
| XareltoRivaroxaban | 14 | $15,471 |
| MounjaroTirzepatide | 13 | $13,590 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $13,238 |
| JanuviaSitagliptin Phosphate | 13 | $9,613 |
| SymbicortBudesonide/Formoterol Fumarate | 19 | $5,906 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 58 | $1,744 |
| Wixela InhubFluticasone Propion/Salmeterol | 12 | $1,623 |
| Nifedipine ErNifedipine | 30 | $1,451 |
| Levothyroxine Sodium | 104 | $1,268 |
| Gabapentin | 58 | $933 |
| Losartan Potassium | 109 | $687 |
| Rosuvastatin Calcium | 76 | $655 |
| Atorvastatin Calcium | 86 | $571 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $13 | $38,12631 claims |
| PfizerEliquis | $162 | $26,41418 claims |
| Johnson & JohnsonXarelto | $140 | $15,47114 claims |
| Lilly USA, LLCMounjaro | $131 | $13,59013 claims |
| GSKTrelegy Ellipta | $110 | $13,23813 claims |
| MerckJanuvia | $18 | $9,61313 claims |
| AstraZenecaSymbicort | $376 | $5,90619 claims |
| Almatica Pharma LLCSertraline Hcl | $25 | $31235 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 14,618 family providers in Florida.
Other family in Fort Pierce
- Marta EuleFort Pierce$91K
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
- Donna OrtizOrlando$417K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.